SAN DIEGO--(BUSINESS WIRE)--Biotheranostics, Inc., today announced that Don Hardison has been appointed to its Board of Directors. Hardison will help steer the company as it continues its exceptional commercial growth driven by molecular diagnostic tests that provide meaningful, personalized information to improve cancer diagnosis and treatment.
